EDRN Lung Team Project #2 validation of molecular biomarkers for the early detection of lung cancer in the setting of indeterminate pulmonary nodules (2024)
Evaluation of a TP53 biomarker for lung cancer risk in nasal brushings and peripheral blood (2024)
Abstract – Development of quality control methods for reliable NGS measurement of methylation in cfDNA (2024)
Deharvengt AMP 2023 Accugenomics_TT063 (2023)
Development of SARS-CoV-2 NGS Internal Standards to Ensure Sufficient Complexity Capture for Variant Detection and Diagnosis (2023)
Monitoring NGS plasma ctDNA sequencing using SNAQ-SEQ ONCO1LB internal controls (2023)
Development of Quality Control Methods for Reliable NGS Measurement of Methylome in Circulating DNA (2022)
The use of Internal Controls in RNA based Next Generation Sequencing panels to quantitate and standardize gene fusion detection. (2021)
SNAQ-SEQ™: Use of synthetic internal standards in conjunction with Poisson Exact Test to call variants in contrived circulating tumor DNA specimens. (2021)
Standardizing NGS Plasma ctDNA Measurements Using SNAQ-SEQ ONCO1LB Internal Controls. (2020)
Novel method for NGS analysis of actionable mutations in circulating tumor DNA specimens: Improve quality control and 20-fold lower sequencing required. (2020)
Use of Synthetic Internal Standards to Measure Very Low Frequency TP53, PIK3CA, and BRAF Somatic Mutations in Normal Airway Epithelial Field of Injury Associated with Lung Cancer Risk. (2020)
Adventitious Agent Detection by NGS. (2020)
Spike-in NGS Controls for Copy Number Assessment and Improved LOD and VAF Confidence. (2020)